Could Recursion Pharmaceuticals Inc’s (NASDAQ: RXRX) Earnings Exceed Your Expectations?
In the last trading session, 31.36 million shares of the Recursion Pharmaceuticals Inc (NASDAQ:RXRX) were traded, and its beta was 0.97. Most recently the company’s